N-Methyl-1-(4-methyloxazol-2-YL)methanamine | 1196151-82-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-Methyl-1-(4-methyloxazol-2-YL)methanamine
• 英文别名: N-methyl-1-(4-methyl-1,3-oxazol-2-yl)methanamine
• CAS: 1196151-82-2
• 化学式: C₆H₁₀N₂O
• 分子量: 126.16
• InChiKey: RMQNATXUUVBYOY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  38.1
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT D'UNE MALADIE RESPIRATOIRE BOVINE OU PORCINE
  申请人：INTERVET INT BV

  公开号：WO2020002238A1

  公开（公告）日：2020-01-02

  The present invention provides compounds of formula (I) for use in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

  本发明提供了用于治疗动物呼吸道疾病，特别是牛或猪呼吸道疾病（BRD和SRD）的化合物（I）的公式。
• Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
  申请人：Intervet Inc.

  公开号：US11034650B2

  公开（公告）日：2021-06-15

  The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

  本发明公开了可用于治疗动物呼吸道疾病，特别是牛或猪呼吸道疾病（BRD 和 SRD）的式（I）化合物。
• Compounds Useful for Treating a Mannheimia Haemolytica or Histophilus Somni Infection
  申请人：Intervet Inc.

  公开号：US20190352256A1

  公开（公告）日：2019-11-21

  The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).
• Compounds for the Treatment of Bovine or Swine Respiratory Disease
  申请人：Intervet Inc.

  公开号：US20200085779A1

  公开（公告）日：2020-03-19

  The present invention provides compounds for use in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).
• COMPOUNDS USEFUL FOR THE TREATMENT OF INFECTION WITH MANNHEIMIA HAEMOLYTICA OR HISTOPHILUS SOMNI
  申请人：Intervet Inc.

  公开号：US20210292284A1

  公开（公告）日：2021-09-23

  The present invention discloses compounds that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD)